Progress to Achieve Balanced State Policy Relevant to Pain Management and Palliative Care

References

• Arnold R, Berger A, Billings J A, et al. Clinical Practice Guidelines for Quality Palliative Care. National Consensus Project for Quality Palliative Care, Brooklyn, NY 2004, (Available at http://www.nationalconsensusproject.org/guideline.pdf)
   Google Scholar
• American Academy of Pain Medicine and American Pain Society. The Use of Opioids for the Treatment of Chronic Pain: A Consensus Statement. American Academy of Pain Medicine and American Pain Society, Glenview, IL 1997, (Available at http://www.painmed.org/productpub/statements/opioidstmt.html)
   Google Scholar
• World Health Organization Cancer and Palliative Care Unit. Cancer Pain Relief: A Guide to Opioid Availability. WHO Collaborating Center for Symptom Evaluation in Cancer Care, Madison, Wisconsin, USA 1992, (Monograph).
   Google Scholar
• Noah L. Challenges in the federal regulation of pain management technologies. J Law Med Ethics 2003; 31(1)55–74
   Google Scholar
• Gilson A M, Joranson D E. U.S. policies relevant to the prescribing of opioid analgesics for the treatment of pain in patients with addictive disease. Clin J Pain 2002; 18(4 suppl)S91–S98, (Available at http://www.medsch.wisc.edu/painpolicy/publicat/02cjpn/index.htm)
   PubMed Web of Science ®Google Scholar
• International Narcotics Control Board. Report of the International Narcotics Control Board for 1995: Availability of Opiates for Medical Needs. United Nations, New York, NY 1996, (Available at http://www.incb.org/e/ind_ar.htm)
   Google Scholar
• World Health Organization. Achieving Balance in National Opioids Control Policy: Guidelines for Assessment. World Health Organization, GenevaSwitzerland 2000, (Available at http://www.medsch.wisc.edu/painpolicy/publicat/00whoabi/00whoabi.htm)
   Google Scholar
• Institute of Medicine Committee on Opportunities in Drug Abuse Research. Pathways of Addiction: Opportunities in Drug Abuse Research. National Academy Press, Washington, DC 1996, (Available at www.nap.edu/catalog/5297.html)
   Google Scholar
• Institute of Medicine Committee on Care at the End of Life. Approaching Death: Improving Care at the End of Life. National Academy Press, Washington, DC 1997, (Available at http://books.nap.edu/catalog/5801.html)
   Google Scholar
• American Medical Association-House of Delegates. Protection for Physicians Who Prescribe Pain Medication H-120.960. American Medical Association, Chicago, IL 2003
   Google Scholar
• Cancer Pain Management Policy Review Group. American Cancer Society Position Statement on Regulatory Barriers to Quality Cancer Pain Management. National Government Relations Department, American Cancer Society. 2001
   Google Scholar
• National Institutes of Health Consensus Development Program. Symptom Management in Cancer: Pain, Depression and Fatigue. Statement prepared following a National Institutes of Health State-of-the-Science Conference on Symptom Management in Cancer, Bethesda, MD, July 15–17, 2002, (Available at http://consensus.nih.gov/ta/022/022_intro.htm)
   Google Scholar
• National Association of Attorneys General. Improving End-of-Life Care: The Role of Attorneys General, W AD Edmondson. National Association of Attorneys General, Washington, DC 2003
   Google Scholar
• Federation of State Medical Boards of the United States Inc. Model Policy for the Use of Controlled Substances for the Treatment of Pain. Federation of State Medical Boards of the United States Inc., Dallas, TX 2004, (Available at http://www.fsmb.org)
   Google Scholar
• Gilson A M, Joranson D E. Controlled substances and pain management: Changes in knowledge and attitudes of state medical regulators. J Pain Symptom Manage 2001; 21(3)227–237, (Available at http://www.medsch.wisc.edu/painpolicy/publicat/01jpsm/index.htm)
   PubMed Web of Science ®Google Scholar
• Gilson A M, Joranson D E, Maurer M A. Improving state medical board policies: Influence of a model. J Law Med Ethics 2003; 31(1)119–129, (Available at http://www.medsch.wisc.edu/painpolicy/publicat/03jlme/index.htm)
   Google Scholar
• Joranson D E, Gilson A M, Dahl J L, Haddox J D. Pain management, controlled substances, and state medical board policy: A decade of change. J Pain Symptom Manage 2002; 23(2)138–147, (Available at http://www.medsch.wisc.edu/painpolicy/publicat/02jpsm1/index.htm)
   PubMed Web of Science ®Google Scholar
• Joranson D E, Gilson A M, Nischik J A. North Carolina, pain management and end-of-life care: Communicating the policy. Fed Bull, J Med Licen & Disc 2002; 88(3)116–119, (Available at http://www.medsch.wisc.edu/painpolicy/publicat/02fsmb/index.htm)
   Google Scholar
• Medical Board of California. New, easy guidelines on prescribing. Action Report 1994; 51: 1, 8
   Google Scholar
• Federation of State Medical Boards of the United States Inc. Model Guidelines for the Use of Controlled Substances for the Treatment of Pain. Federation of State Medical Boards of the United States Inc, Euless, TX 1998, (Available at http://www.fsmb.org)
   Google Scholar
• Federation of State Medical Boards of the United States Inc. Position of the Federation of State Medical Boards in support of adoption of pain management guidelines. 2000
   Google Scholar
• Joranson D E, Gilson A M, Ryan K M, et al. Achieving Balance in Federal and State Pain Policy: A Guide to Evaluation. Pain & Policy Studies Group, University of Wisconsin Comprehensive Cancer Center, Madison, WI 2000, (Available at http://www.medsch.wisc.edu/painpolicy/eguide2000/index.html)
   Google Scholar
• Pain & Policy Studies Group. Achieving Balance in Federal and State Pain Policy: A Guide to Evaluation, Second edition. University of Wisconsin Comprehensive Cancer Center, Madison, WI 2003, (Available at http://www.medsch.wisc.edu/painpolicy/2003_balance/)
   Google Scholar
• Dahl J L, Joranson D E. Cancer pain: the US responds. Palliat Med 1992; 6: 94–97
   Google Scholar
• Dahl J L, Joranson D E, Weissman D E. The Wisconsin cancer pain initiative: a progress report. Am J Hospice Care 1989; 6(6)39–43
   Google Scholar
• National Conference of Commissioners on Uniform State Laws. Uniform Controlled Substances Act. Adopted at its Annual Conference Meeting in its One-Hundred-and-Third-Year, Chicago, IL, July 29-August 5, 1994. NCCUSL, Chicago, IL
   Google Scholar
• Controlled Substances Act. 1970, Pub L No. 91–513, 84 Stat 1242
   Google Scholar
• Controlled Substances Act, Title 21 USC §801(1). (Available at http://www.deadiversion.usdoj.gov/21cfr/21usc/21iausct.htm)
   Google Scholar
• Joranson D E, Gilson A M. Controlled substances, medical practice, and the law. Psychiatric Practice Under Fire: the Influence Of Government, the Media, and Special Interests on Somatic Therapies. 1st ed, H I Schwartz. American Psychiatric Press, Inc., Washington, DC 1994; 173–194, (Available at http://www.medsch.wisc.edu/painpolicy/publicat/94appcs.htm)
   Google Scholar
• Joranson D E. Federal and state regulation of opioids. J Pain Symptom Manage 1990; 5((Suppl.)(1))S12–S23, (Available at http://www.medsch.wisc.edu/painpolicy/publicat/90jpsmf.htm)
   Google Scholar
• Last Acts. Means to a Better End: A Report on Dying in America Today. Last Acts National Program Office, Washington, DC 2002, (Available at www.lastacts.org/)
   Google Scholar
• Pain & Policy Studies Group. Achieving Balance in State Pain Policy: A Progress Report Card. University of Wisconsin Comprehensive Cancer Center, Madison, WI 2003, (Available at http://www.medsch.wisc.edu/painpolicy/2003_balance/)
   Google Scholar
• Dahl J L, Bennett M E, Bromley M D, Joranson D E. Success of the State Pain Initiatives. Cancer Pract 2002; 10(Suppl. 1)S9–S13, (Available at http://www.aacpi.wisc.edu/images/SPI.pdf)
   Google Scholar
• Drug Enforcement Administration, Last Acts, Pain & Policy Studies Group, et al. Promoting Pain Relief and Preventing Abuse of Pain Medications: A Critical Balancing Act. Last Acts, Washington, DC 2001, (Available at http://www.medsch.wisc.edu/painpolicy/dea01.htm)
   Google Scholar
• Hoffmann D E, Tarzian A J. Achieving the right balance in oversight of physician opioid prescribing for pain: The role of state medical boards. J Law Med Ethics 2003; 31(1)21–40, (Available at http://www.aslme.org/pub_jlme/index_31.php)
   Google Scholar
• United Nations. Single Convention on Narcotic Drugs, 1961. United Nations, GenevaSwitzerland 1973
   Google Scholar
• Federation of State Medical Boards of the United States Inc. A Guide to the Essentials of a Modern Medical Practice Act. 9th ed. Federation of State Medical Boards, Dallas, TX 2000, (Available at http://www.fsmb.org/)
   Google Scholar
• American Alliance of Cancer Pain Initiatives. Statement on State Prescription Monitoring Programs. AACPI, Madison, WI 2002, (Available at http://www.aacpi.wisc.edu/regulatory/regulatory.html)
   Google Scholar
• Brushwood D B. Maximizing the value of electronic prescription monitoring programs. J Law Med Ethics 2003; 31(1)41–54, (Available at http://www.aslme.org/mayday.php)
   Google Scholar
• American Alliance of Cancer Pain Initiatives. Statement on Intractable Pain Treatment Acts (IPTA). AACPI, Madison, WI 2004
   Google Scholar
• Hawryluck L A, Harvey W RC, Lemieux-Charles L, Singer P A. Consensus guidelines on analgesia and sedation in dying intensive care unit patients. BMC Med Ethics 2002; 3: 1–9, (Available at http://www.biomedcentral.com/1472–6939/3/3)
   Google Scholar
• Institute of Medicine National Cancer Policy Board. Improving Palliative Care for Cancer, K M Foley, H Gelband. National Academy Press, Washington, DC 2001, (Available at http://www.nap.edu/catalog/10149.html)
   Google Scholar
• Meisel A, Snyder L, Quill T. Seven legal barriers to end-of-life care: Myths, realities, and grains of truth. JAMA 2000; 284(19)2495–2501
   Google Scholar
• Zerzan J, Stearns S, Hanson L. Access to palliative care and hospice in nursing homes. JAMA 2000; 284(19)2489–2494
   Web of Science ®Google Scholar
• Dahl J L. Working with regulators to improve the standard of care in pain management: The U.S. experience. J Pain Symptom Manage 2002; 24(2)136–146
   Google Scholar
• Ferrante F M. Principles of opioid pharmacotherapy: practical implications of basic mechanisms. J Pain Symptom Manage 1996; 11(5)265–273
   PubMedGoogle Scholar
• Furstenberg C T, Ahles T A, Whedon M B, et al. Knowledge and attitudes of health-care providers toward cancer pain management: a comparison of physicians, nurses, and pharmacists in the State of New Hampshire. J Pain Symptom Manage 1998; 15(6)335–349
   PubMedGoogle Scholar
• Drug Enforcement Administration, Last Acts, Pain & Policy Studies Group. Prescription Pain Medications: Frequently Asked Questions and Answers for Health Care Professionals and Law Enforcement Personnel. Drug Enforcement Administration, Washington, DC 2004, (Available at http://www.deadiversion.usdoj.gov/faq/pain_meds_faqs.pdf)
   Google Scholar
• Gregoire C O. When the law is good medicine. J Law Med Ethics 2002; 30(3)41–44
   Google Scholar
• Ziegler S J, Lovrich N P. Pain relief, prescription drugs, and prosecution: a four-state survey of chief prosecutors. J Law Med Ethics 2003; 31(1)75–100
   PubMed Web of Science ®Google Scholar
• Passik S. Letter to the Editor: Same as it ever was? Life after the Oxycontin Media Frenzy. J Pain Symptom Manage 2003; 25(3)199–201
   PubMed Web of Science ®Google Scholar